TAL
DMIIU

TIG Advisors LLC’s Drugs Made In America Acquisition II Corp Unit DMIIU Stock Holding History

TIG Advisors LLC’s Portfolio DMIIU Stock Details DMIIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-500,000
Closed -$5.02M – 152
2026
Q1 		$5.02M Hold
500,000
– – 0.23% 47
2025
Q4 		$5.01M Hold
500,000
– – 0.23% 35
2025
Q3 		$4.97M Buy
+500,000
New +$4.99M 0.3% 36

Other funds holding DMIIU

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

TIG Advisors LLC's DMIIU Position: Q2 2026 in Review

TIG Advisors LLC sold out of Drugs Made In America Acquisition II Corp Unit (DMIIU) in Q2 2026, closing a stake of 500,000 shares — an estimated $5.02M sold.

TIG Advisors LLC first reported a position in DMIIU in Q3 2025 and held it in 3 quarters. The position peaked at $5.02M in Q1 2026. 11 funds tracked by Wall St. Rank hold DMIIU as of Q2 2026.

  • TIG Advisors LLC reported no remaining Drugs Made In America Acquisition II Corp Unit position as of Q2 2026 after selling out during the quarter.
  • TIG Advisors LLC sold 500,000 Drugs Made In America Acquisition II Corp Unit shares in Q2 2026, an estimated $5.02M.
  • TIG Advisors LLC first reported a position in Drugs Made In America Acquisition II Corp Unit in Q3 2025 and held it in 3 quarters.
  • TIG Advisors LLC's Drugs Made In America Acquisition II Corp Unit position peaked at $5.02M in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Unit as of Q2 2026.

Based on TIG Advisors LLC's 13F filing for Q2 2026, filed 14 Aug 2026.